Jim Ranger‐Moore

Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma

Bettina G. Papouchado, Jonathan Myles, Ricardo V. Lloyd et al. · The American Journal of Surgical Pathology · 2010 · 99 citations

Medicine, Oncology, Pathology +17

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of <scp>HPV</scp>‐positive women: Results from the <scp>IMPACT</scp> trial

Thomas C. Wright, Mark H. Stoler, Jim Ranger‐Moore et al. · International Journal of Cancer · 2021 · 66 citations · Full text

Medicine, Oncology, Pathology +17

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

Hiroaki Nitta, Brian Kelly, Mary Padilla et al. · Diagnostic Pathology · 2012 · 59 citations · Full text

Medicine, Molecular Biology, Oncology +16

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Sasagu Kurozumi, Mary Padilla, Masafumi Kurosumi et al. · Breast Cancer Research and Treatment · 2016 · 48 citations · Full text

Medicine, Molecular Biology, Oncology +15

EGFR Protein Expression in Non–Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor—A Novel Antibody for Immunohistochemistry or AQUA Technology

Céline Mascaux, Murry W. Wynes, Yasufumi Kato et al. · Clinical Cancer Research · 2011 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17